Could umbilical cord stem cells help damaged lungs?
NCT ID NCT06534528
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial will test whether injecting stem cells from donated umbilical cords into the lungs is safe for people with interstitial lung disease (ILD). Twenty-four adults with ILD will receive different doses through a bronchoscope. The main goal is to find the safest dose and watch for side effects, while also checking if lung function improves.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- human umbilical cord mesenchymal stem cells
- What this could lead to
- If this works, it could point toward a new way to slow or manage interstitial lung disease, potentially improving breathing and quality of life.
- What could go wrong
- This is a very early Phase 1 trial with only 24 people, focused on safety. It may not show any benefit, and there are risks like serious side effects or no improvement in lung function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI catch lung scarring that doctors might miss?
- Can arm workouts boost oxygen use in lung disease?
- Spotting hidden blood clots in scarred lungs: a study hunts for clues
- Virtual Nurse-Social worker team aims to ease symptoms for veterans with heart failure and COPD
- AI outruns radiologists in detecting early lung scarring
- Smart home tech could help lung patients breathe easier at home